Skip to main content
. 2020 Feb 10;112(10):1038–1046. doi: 10.1093/jnci/djaa011

Table 3.

Distributions of ELISA serum antibody concentration levels and SEAP neutralization titers for HPV16 and HPV18 at years nine and 11

Assay Metric Three doses
Two doses (0/6 mo)
One dose
GM (95% CI) IQR GM (95% CI) IQR GM (95% CI) IQR
HPV 16 ELISA antibody concentration
 ELISA antibody  concentration, EU/mL Year 9 699 (606 to 807) 394–1265 414 (328 to 524) 197–813 172 (141 to 209) 83–319
Year 11 664 (570 to 772) 383–1309 340 (267 to 434) 170–684 176 (145 to 214) 84–370
Change, % (95%CI) –1.6 (–8.6 to 5.5) –17.9 (–28.5 to –7.4) 0.3 (–13.4 to 13.9)
Ratio of GM 0.95 (0.89–1.01) 0.82 (0.76–0.89) 1.03 (0.94–1.13)
HPV18 ELISA antibody concentration
 ELISA antibody  concentration, EU/mL Year 9 292 (249 to 342) 163–532 210 (171 to 259) 119–426 102 (83 to 125) 48–223
Year 11 275 (234 to 323) 160–518 194 (156 to 241) 117–384 109 (89 to 133) 51–220
Change, % (95%CI) –4.0 (–13.6 to 5.6) –2.1 (–22.5 to 18.4) –1.3 (–14.0 to 11.5)
Ratio of GM 0.94 (0.88–1.01) 0.92 (0.83–1.02) 1.07 (0.99–1.16)
HPV 16 SEAP-NA neutralization titer
 SEAP-NA antibody titer Year 9 1776 (1389 to 2270) 1014–3114 771 (612 to 970) 382–1484 285 (229 to 355) 120–654
Year 11 1565 (1227 to 1997) 924–2916 626 (491 to 798) 323–1405 285 (233 to 349) 133–608
Change, % (95%CI) –10.5 (–21.7 to 0.7) –17.2 (–28.1 to –6.4) –11.5 (–29.7 to 6.7)
Ratio of GM 0.88 (0.81–0.96) 0.81 (0.75–0.88) 1.00 (0.90–1.11)
HPV18 SEAP-NA neutralization titer
 SEAP-NA antibody titer Year 9 856 (645 to 1136) 425–1615 531 (415 to 678) 295–1092 216 (170 to 273) 93–504
Year 11 792 (588 to 1065) 371–1573 489 (371 to 644) 217–1080 233 (184 to 296) 96–551
Change, % (95%CI) –2.6 (–15.9 to 10.6) 14.6 (–33.2 to 62.4) 6.8 (–7.4 to 21.0)
Ratio of GM 0.92 (0.81–1.06) 0.92 (0.80–1.06) 1.08 (0.98–1.19)
*

CI = confidence interval; ELISA = enzyme-linked immunosorbent assay; GM = geometric mean; IQR = interquartile range; SEAP-NA = secreted alkaline phosphatase-based pseudovirion neutralization assay.